Usually these funds will:
- have over 80% invested in biotechnology and healthcare securities;
- less than 80% in debt; and
- an investment objective/policy to invest in biotechnology or healthcare securities
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated